Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-16-004365
Filing Date
2016-03-24
Accepted
2016-03-24 16:05:52
Documents
9
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K axsm-20151231x10k.htm 10-K 2367655
2 EX-23.1 axsm-20151231ex231bddceb.htm EX-23.1 8335
3 EX-31.1 axsm-20151231ex3115e60d8.htm EX-31.1 12357
4 EX-31.2 axsm-20151231ex3121f5904.htm EX-31.2 12583
5 EX-32.1 axsm-20151231ex3217b73a1.htm EX-32.1 5629
6 EX-32.2 axsm-20151231ex322a9bc12.htm EX-32.2 5617
7 GRAPHIC axsm20151231x10k001.jpg GRAPHIC 177577
8 GRAPHIC axsm20151231x10k002.jpg GRAPHIC 28962
9 GRAPHIC axsm20151231x10k003.jpg GRAPHIC 49698
  Complete submission text file 0001558370-16-004365.txt   2766367
Mailing Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004
Business Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004 212-203-5072
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37635 | Film No.: 161527105
SIC: 2834 Pharmaceutical Preparations